| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial MP Manns, JG McHutchison, SC Gordon, VK Rustgi, M Shiffman, ... The Lancet 358 (9286), 958-965, 2001 | 8332 | 2001 |
| Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C JG McHutchison, SC Gordon, ER Schiff, ML Shiffman, WM Lee, VK Rustgi, ... New England Journal of Medicine 339 (21), 1485-1492, 1998 | 4567 | 1998 |
| Boceprevir for untreated chronic HCV genotype 1 infection F Poordad, J McCone Jr, BR Bacon, S Bruno, MP Manns, MS Sulkowski, ... New England Journal of Medicine 364 (13), 1195-1206, 2011 | 3382 | 2011 |
| Liver biopsy DC Rockey, SH Caldwell, ZD Goodman, RC Nelson, AD Smith Hepatology 49 (3), 1017-1044, 2009 | 2413 | 2009 |
| Boceprevir for previously treated chronic HCV genotype 1 infection BR Bacon, SC Gordon, E Lawitz, P Marcellin, JM Vierling, S Zeuzem, ... New England Journal of Medicine 364 (13), 1207-1217, 2011 | 2254 | 2011 |
| A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B TT Chang, RG Gish, R De Man, A Gadano, J Sollano, YC Chao, AS Lok, ... New England Journal of Medicine 354 (10), 1001-1010, 2006 | 2077 | 2006 |
| Adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B P Marcellin, TT Chang, SG Lim, MJ Tong, W Sievert, ML Shiffman, ... New England Journal of Medicine 348 (9), 808-816, 2003 | 2066 | 2003 |
| Lamivudine as initial treatment for chronic hepatitis B in the United States JL Dienstag, ER Schiff, TL Wright, RP Perrillo, HWL Hann, Z Goodman, ... New England Journal of Medicine 341 (17), 1256-1263, 1999 | 1964 | 1999 |
| Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B CL Lai, D Shouval, AS Lok, TT Chang, H Cheinquer, Z Goodman, ... New England Journal of Medicine 354 (10), 1011-1020, 2006 | 1690 | 2006 |
| Recombinant interferon alfa therapy for chronic hepatitis C AM Di Bisceglie, P Martin, C Kassianides, M Lisker-Melman, L Murray, ... New England Journal of Medicine 321 (22), 1506-1510, 1989 | 1554 | 1989 |
| Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C T Poynard, J McHutchison, M Manns, C Trepo, K Lindsay, Z Goodman, ... Gastroenterology 122 (5), 1303-1313, 2002 | 1485 | 2002 |
| Adefovir dipivoxil for the treatment of hepatitis B e antigen–negative chronic hepatitis B SJ Hadziyannis, NC Tassopoulos, EJ Heathcote, TT Chang, G Kitis, ... New England Journal of Medicine 348 (9), 800-807, 2003 | 1443 | 2003 |
| Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B TT Chang, YF Liaw, SS Wu, E Schiff, KH Han, CL Lai, R Safadi, SS Lee, ... Hepatology 52 (3), 886-893, 2010 | 1264 | 2010 |
| Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy B Werle–Lapostolle, S Bowden, S Locarnini, K Wursthorn, J Petersen, ... Gastroenterology 126 (7), 1750-1758, 2004 | 1198 | 2004 |
| Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years SJ Hadziyannis, NC Tassopoulos, EJ Heathcote, TT Chang, G Kitis, ... Gastroenterology 131 (6), 1743-1751, 2006 | 1185 | 2006 |
| Telbivudine versus lamivudine in patients with chronic hepatitis B CL Lai, E Gane, YF Liaw, CW Hsu, S Thongsawat, Y Wang, Y Chen, ... New England Journal of Medicine 357 (25), 2576-2588, 2007 | 1166 | 2007 |
| Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1081 | 2019 |
| Grading and staging systems for inflammation and fibrosis in chronic liver diseases ZD Goodman Journal of hepatology 47 (4), 598-607, 2007 | 1015 | 2007 |
| Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C T Poynard, V Ratziu, F Charlotte, Z Goodman, J McHutchison, J Albrecht Journal of hepatology 34 (5), 730-739, 2001 | 1005 | 2001 |
| A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C KL Lindsay, C Trepo, T Heintges, ML Shiffman, SC Gordon, JC Hoefs, ... Hepatology 34 (2), 395-403, 2001 | 967 | 2001 |
